GLP-1 receptor agonists like Semaglutide and Liraglutide have demonstrated effectiveness in reducing insulin resistance, normalizing menstruation, and promoting weight loss in PCOS patients
Studies in models of Parkinsons disease suggest these medications may decrease inflammation, enhance cellular energy production, and improve the function of critical brain cells associated with movement all processes that are known to be impacted by Parkinsons
Standard doses run 1 to 3 mg per injection
Instead, they belong in a medically guided program where members are supported, monitored, and given the tools to succeed
My first O-Shot yielded noticable symptom improvement from my ongoing urethral burning and inflammation, allowing me to sleep 3-4 hours without having to get up and pee
Resmetirom is not recommended for patients with cirrhosis, in whom it has not been tested